• Asia’s leading and most highly-anticipated event
  •  Highlights on market access and commercialization case study
  •   The region’s largest gathering of leading and future stakeholders across the value chain

With continued growth and evolving market dynamics, sales of global biosimilars is forecasted to reach $25 billion in the year of 2020 and Asia is expected to ride on the uphill trend. Biosimilar regulations are expected to change and having the right commercialization strategy will be the key to accessing new markets.

At IBC’s Biosimilars Asia Conference, top industry players will explore practical strategies for gaining access to emerging markets, clarifying regulatory pathways and clinical approvals, evaluating business models, risks and investment opportunities, pricing and commercialization strategies and successful case studies.

2015 Conference Themes Include:

  • Latest update on Biosimilars and managing evolving regulations
  • Pricing and market access in biosimilars markets
  • Investment opportunities, successful business models and competitive strategies
  • Strategic collaboration and valuation of biosimilars businesses
  • Opportunities and challenges to commercialize biosimilars
  • Latest in clinical development and approvals
  • Legal and IP issues and concerns
About the Biopharma Development & Production Week

The Biopharma Development & Production Week is the leading industry platform for pharma, biotech, CMOs, CROs, research institutes, investors and industry stakeholders to meet, network and discuss current industry trends, establish business partnerships and be updated on investment opportunities in China and surrounding Asia.  For more information visit www.biopharmaproduction.com

3 Co-located events under one roof

Agenda at a Glance

Pre Conference Workshop, 19 May

  • Monoclonal Antibodies (Mabs)
  • Commercialization Strategy in Biosimilar

Conference Day 1, 20 May

Conference Day 2, 21 May

  • Biopharma Visionary Keynote Sessions
  • Biosimilars Landscape and Policy Changes
  • Show Case from Regional Companies and Successful Case Study
  • Technology Transfer and Manufacturing

Networking Lunch

  • Market Access & Commercialization
  • Strategic Collaboration and Innovative Strategy
  • R&D and Clinical Trails Development
  • Legal and IP Issues

Post Conference Workshop, 22 May

  • Biosimilar Clinical Trials & Approvals
  • Clarifying Biosimilar Regulations in China


Produced bySupporting AssociationBronze Sponsors 

Media Partners